Skip to contentB
Biofrontera Inc.
B
BFRIBiofrontera Inc. Q3 2025 · 10-Q
Revenue$6.99M$6.99M−22.5% vs Q3 2024 Net Income-$6.65M-$6.65MN/M vs Q3 2024 EPS Diluted-$0.62-$0.62N/M vs Q3 2024 Operating Income-$6,278,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biofrontera Inc. · CIK 1858685 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$3,822,000N/M Margins · derivedOperating margin-89.8%−34.8 pt vs Q3 2024
Net margin-95.1%−32.2 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 12, 2025 · 43 d after period end